Authors : Susmita Behera, Nihar Ranjan Sahoo, Rashmita Panigrahi, Chitta Ranjan Prasad
DOI : 10.18231/j.pjms.2021.109
Volume : 11
Issue : 3
Year : 2021
Page No : 557-560
Covid-19 is currently a big threat to global health. As many drugs are tried but currently there is no approved treatment for covid-19. The management plan is supportive care with supplemental oxygen and mechanical ventilation. Directorate General of Health Services (DGHS), Government of India has approved convalescent plasma from patients recovered from Covid-19 for treatment of moderate to severe COVID-19 infection cases. Plasma bank of Odisha blood bank, MKCG MCH was involved in the convalescent plasma extraction for treatment of covid-19 patients. Prospective study was undertaken from 5 August 2020 to 5 December, 2020 to evaluate the plasma donors with respect to age wise distribution and common blood group affected. A total 340 donors donated convalescent plasma which commonly were in the age group 31-40 years followed by 21-30 years. Most common donors were from the O+ve blood group and no donors from AB-ve group. Female donors constituted only 1.7 % of total donors. It might be worthwhile to test the safety and efficacy of convalescent plasma transfusion in SARS-CoV-2 infected patients. CP therapy might be a promising treatment option for COVID-19 rescue. Convalescent plasma has been considered a potential modality of treatment for COVID-19 infection.
Keywords: Covid 19, Convalescent Plasma, Plasma Therapy